On January 12, 2023, an extraordinary general meeting was held in SynAct Pharma AB (publ). All resolutions were adopted with the required majority of votes.
Documents
- Minutes from extraordinary general meeting January 12, 2023 - English
- Bulletin from the extraordinary general meeting of SynAct Pharma AB January 12, 2023 - English
- Notice of extraordinary general meeting January 12, 2023 December 12, 2022 - English
- Power of Attorney English
- Annual report of 2021 with a note on distribution of profit English
- Proposal for resolution on (A) approval of acquisition of TXP Pharma AG (related party transaction); and (B) issue of new shares in kind English
- Proposal for resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants English
- The board’s report on material events pursuant to Chap. 13 Sec. 6 of the Swedish Companies Act English
- The board’s report on assets to be contributed in kind pursuant to Chap. 13 Sec. 7 of the Swedish Companies Act English
- The board’s report on material events pursuant to Chap. 13 Sec. 6 and Chap. 14 Sec. 8 of the Swedish Companies Act English
- Auditor's statement pursuant to Chap. 13 Sec. 6 of the Swedish Companies Act English
- Auditor's statement pursuant to Chap. 13 Sec. 8 of the Swedish Companies Act English
- Auditor's statement pursuant to Chapter 13 Sec. 6 and Chap. 14 Sec. 8 of the Swedish Companies Act English
- Fairness letter TXP transaction E&Y English